United States - English - NLM (National Library of Medicine)

goyescas of fla - drug facts, active ingredients: purpose, (in each 5 ml. tsp), dextromethorphan hbr usp 10mg cough suppresant, guaifenesin usp 100mg expectorant, phenylephrine hci usp 5mg nasal decongestant - use: helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes. temporarily relieves these symptoms occurring with a cold, nasal congestion, cough due to minor throat and bronchial irritation. active ingredients: purpose (in each 5 ml. tsp) dextromethorphan hbr usp 10mg cough suppresant guaifenesin usp 100mg expectorant phenylephrine hci usp 5mg nasal decongestant

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

herbion pakistan pvt. ltd. - adhadota vasica, glycyrrhiza glabra, piper longum, viola odorata, hyssopus officinalis, alpinia galanga, cordia latifolia, altaea officinalis, zizyphus vulgaris, onosma bracteata - syrup - 60mg/ml+ 7,5mg/ml+ 10mg/ml+ 2,5mg/ml+ 5mg/ml+ 5mg/ml+ 10mg/ml+ 10mg/ml+ 10mg/ml+ 10mg/ml

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - amoxicillin trihydrate, quantity: 25 mg/ml - oral liquid, powder for - excipient ingredients: colloidal anhydrous silica; silicon dioxide; disodium edetate; sodium benzoate; xanthan gum; saccharin sodium; sorbitol; flavour - indications as at 6 november 2003: cilamox is indicated for the treatment of infections due to susceptible strains of the sensitive organisms. gram-negative: h. influenzae, e coli, pr. mirabilis, and n. gonorrhoeae. gram-positive: streptococcus species, s. pneumoniae, non-penicllinase producing staphlococci and bacillus anthracis. note 1: cilamox may be useful in instituting therapy prior to bacteriology; however, bacteriological studies to determine the causative organisms and their sensitivity to cilamox should be performed. note 2: penicillins are now generally regarded only as adjunctive to some other established first-line antibiotic therapy in the treatment and post-exposure prophylaxis of anthrax, because of concerns of constitutive and inducible beta-lactamase in bacillus anthracis. if use of amoxycillin is contemplated, appropriate bacteriological studies must be performed by a reliable and established test method. amoxycillin may then be suitable if the specific b. anthracis strain has been shown definitively to be sensitive to penicillin/amaxycillin.

Namibia - English - Namibia Medicines Regulatory Council

sanofi-aventis s.a (pty) ltd - carbocisteine - syrup - each 5ml syrup contains carbocysteine 250 mg

United States - English - NLM (National Library of Medicine)

dolgencorp, inc. (dollar general & rexall) - dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq) - cough suppressant expectorant -  temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold - helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes

Ireland - English - HPRA (Health Products Regulatory Authority)

phoenix labs - methoxyphenamine hydrochloride; sodium citrate; guaiphenesin - syrup - 20 mg/5ml/100 mg/5ml/200 mg/5ml - expectorants; combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

pierre fabre medicament - carbocisteine - oral solution - 250/5 mg/ml - carbocisteine

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - sodium valproate, quantity: 40 mg/ml - oral liquid - excipient ingredients: sorbitol; sodium propyl hydroxybenzoate; sodium methyl hydroxybenzoate; saccharin sodium; brilliant scarlet 4r; purified water; sucrose; flavour - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy. mania: for the treatment of mania where other therapy has proved inadequate or is inappropriate

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

adcock ingram limited - syrup - see ingredients - each 5,0 ml syrup contains zidovudine 50,0 mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pinewood healthcare - paracetamol - oral suspension - 24mg/1ml